Funding for this research was provided by:
Received: 3 January 2020
Accepted: 27 April 2020
First Online: 14 May 2020
Ethics approval and consent to participate
: This study was registered with the Malaysian National Medical Research Registry (NMRR -17-2614-38966). This study was also approved by the Malaysian Research and Ethics Committee. Prior to each interview, written consents and assents were obtained from both caregivers & patients who were willing to participate.
: Not Applicable.
: Asrul Akmal Shafie and Hishamshah Mohd Ibrahim were engaged by Novartis for speaking engagements.